Skip to main content

Table 1 Summary of demographics of human subjects studied.

From: Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains

 

Group

 

AD ( n = 16)

PA ( n = 8)

NDC ( n = 7)

Age

82 (66 to 99)

80 (66 to 90)

76 (66 to 87)

Gender

   

   M

8 (50%)

6 (75%)

5 (71%)

   F

8 (50%)

2 (25%)

2 (29%)

Braak

   

2.0

0 (0%)

4 (50%)

4 (57%)

2.5

0 (0%)

1 (13%)

1 (14%)

3.0

0 (0%)

3 (38%)

2 (29%)

3.5

0 (0%)

0 (0%)

0 (0%)

4.0

2 (13%)

0 (0%)

0 (0%)

4.5

2 (13%)

0 (0%)

0 (0%)

5.0

7 (44%)

0 (0%)

0 (0%)

5.5

2 (13%)

0 (0%)

0 (0%)

6.0

3 (19%)

0 (0%)

0 (0%)

CAA

   

0

6 (38%)

5 (63%)

5 (71%)

0 - 1+

1 (6%)

0 (0%)

1 (14%)

1+

6 (38%)

0 (0%)

1 (14%)

1+ - 2+

1 (6%)

0 (0%)

0 (0%)

2+

1 (6%)

1 (13%)

0 (0%)

2+ - 3+

0 (0%)

1 (13%)

0 (0%)

3+

0 (0%)

1 (13%)

0 (0%)

4+

1 (6%)

0 (0%)

0 (0%)

  1. Median ages (age range), gender distribution, Braak score and CAA score are denoted. CAA scoring was done by post-mortem neuropathologic analysis by DW. AD, Alzheimers disease; CAA, cerebral amyloid angiography; F, female; M, male; n, number; NDC, non-demented controls; PA, Pathological aging.